Terry Haley

Design and synthesis of monocyclic β-lactams as mechanism-based inhibitors of human cytomegalovirus protease

Alan D. Borthwick, Gordon Weingarten, Terry Haley et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 167 citations · Full text

Mechanism-based Inhibitors, Medicine, Drug Discovery +8

Kinetics, Stoichiometry, and Identification of the Reactive Thiolate in the Inactivation of UDP-GlcNAc Enolpyruvoyl Transferase by the Antibiotic Fosfomycin

John L. Marquardt, Eric D. Brown, William S. Lane et al. · Biochemistry · 1994 · 143 citations

Bioorganic Chemistry, Antimicrobial Chemotherapy, Enzymatic Modification +19

Molecular Ontogeny of Donor-Derived Follicular Lymphomas Occurring after Hematopoietic Cell Transplantation

Oliver Weigert, Nadja Kopp, Andrew A. Lane et al. · Cancer Discovery · 2011 · 98 citations · Full text

Design and Synthesis of Pyrrolidine-5,5-<i>trans-</i>lactams (5-Oxohexahydropyrrolo[3,2-<i>b</i>]pyrroles) as Novel Mechanism-Based Inhibitors of Human Cytomegalovirus Protease. 2. Potency and Chirality

Alan D. Borthwick, Andrew J. Crame, Peter Ertl et al. · Journal of Medicinal Chemistry · 2001 · 72 citations · Full text

Hcmv Deltaala Protease, Bioorganic Chemistry, Novel Mechanism-based Inhibitors +17

Design and Synthesis of Pyrrolidine-5,5‘-<i>trans-</i>Lactams (5-Oxo-hexahydropyrrolo[3,2-<i>b</i>]pyrroles) as Novel Mechanism-Based Inhibitors of Human Cytomegalovirus Protease. 4. Antiviral Activity and Plasma Stability

Alan D. Borthwick, Dave E. Davies, Peter Ertl et al. · Journal of Medicinal Chemistry · 2003 · 71 citations · Full text